Castle Biosciences, Inc.CSTLNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+49.9%
5Y CAGR+61.9%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+49.9%/yr
vs +56.8%/yr prior
5Y CAGR
+61.9%/yr
Recent deceleration
Acceleration
-6.9pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
11.1x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $107.88M | +79.2% |
| 2024 | $60.20M | +33.8% |
| 2023 | $44.98M | +40.5% |
| 2022 | $32.01M | +102.3% |
| 2021 | $15.82M | +63.4% |
| 2020 | $9.69M | +32.5% |
| 2019 | $7.31M | +38.0% |
| 2018 | $5.30M | +7.6% |
| 2017 | $4.92M | - |